MediSapiens is excited to launch the evolution of its Genomics Software Suite (GSS), version 1.2. GSS is a scalable, adaptable SaaS solution for data-driven operations. GSS allows our partners to use and apply large cohorts of omics data with a fast return of results. It offers great flexibility in managing omics data sources, combining these…
Read article
MediSapiens wishes you very Happy Holidays and look forward to work with you in 2022!
Read article Genomic medicine may facilitate predictive, preventive and personalized (or precision) health care, improve cost efficiency of medical care and promote efficacy, speed and success rates of drug development. The utilization of the world’s increasing genomic and clinical data resources holds the promise of driving new breakthroughs in drug development, disease prevention, diagnostics and patient care.…
Read article
29 Nov – 3 Dec 2021 Meet our VP of Sales Hans Garritzen at the event. Contact him via the Biotechgate digital app or via our website contact form for a meeting.
Read article MediSapiens and Predicell (Helsinki and Espoo, Finland) are excited to announce their cooperation in combining AI-driven solutions for (preventive) healthcare using wearables with genomics data capabilities. The cooperation will address the key challenges in fully utilizing all the available RWE and genomic data for the benefit of patients: identify risks and prevent these in time.…
Read article After the successful launch of the MediSapiens Genomics Software Suite (GSS) in February 2021, we are excited to announce the release of the much advanced GSS 1.1 version! Based on the operational feedback of our users and our development roadmap, GSS 1.1 offers improved capabilities, tool integration and features to support pharma, hospital groups, academia,…
Read article
Thank you for your interest in IST Online, one of the largest fully integrated and annotated human gene expression data sources. After 12 years in use, IST Online website was closed on 6. July, 2021 IST has the expression of human genes across the 60 healthy tissues, 104 malignant and 64 other disease types and…
Read article
MediSapiens supports Bayer in its Future Clinical Trials program, where Bayer is working to transform clinical trials with data science and patient-centricity. MediSapiens provides its data model knowledge (such as OMOP), data quality capabilities and data management know-how to Bayer, among others. To hear more, listen to Bayer’s Jussi Leinonen present the Future Clinical Trials…
Read article MediSapiens and VEIL.AI ( Helsinki, Finland) are excited to announce their cooperation in launching an innovative process for the anonymization and harmonization of clinical data. This process will address the key challenges in fully utilizing data for the benefit of patients: access to data and combining data from several sources. The joint MediSapiens-VEIL.AI process will…
Read article
BCB Medical and MediSapiens are thrilled to announce their cooperation in the field of data standardization. Both BCB and MediSapiens are participants in the EHDEN, European Health Data & Evidence Network. In the EHDEN, BCB Medical is a data partner, providing data for conversion to the OMOP Common Data Model, while MediSapiens is currently the…
Read article